This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated
